| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-akt | 46 | 2024 | 2503 | 6.940 |
Why?
|
| Phosphatidylinositol 3-Kinases | 35 | 2023 | 2938 | 3.430 |
Why?
|
| Protein Kinase C | 34 | 2012 | 1227 | 3.270 |
Why?
|
| Signal Transduction | 50 | 2024 | 23403 | 2.020 |
Why?
|
| NFATC Transcription Factors | 7 | 2015 | 381 | 1.890 |
Why?
|
| Breast Neoplasms | 33 | 2024 | 20822 | 1.710 |
Why?
|
| Phosphoric Monoester Hydrolases | 5 | 2020 | 431 | 1.590 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 8 | 2021 | 890 | 1.570 |
Why?
|
| Neoplasm Invasiveness | 14 | 2016 | 3616 | 1.520 |
Why?
|
| Phosphatidylinositol 3-Kinase | 3 | 2022 | 130 | 1.410 |
Why?
|
| Cell Movement | 15 | 2017 | 5217 | 1.300 |
Why?
|
| Isoenzymes | 19 | 2017 | 1726 | 1.290 |
Why?
|
| Phosphorylation | 43 | 2024 | 8436 | 1.150 |
Why?
|
| Phosphatidylinositols | 5 | 2020 | 291 | 1.150 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2020 | 783 | 0.920 |
Why?
|
| Phosphoproteins | 8 | 2011 | 2440 | 0.920 |
Why?
|
| Protein Isoforms | 7 | 2018 | 1730 | 0.910 |
Why?
|
| Pantothenic Acid | 1 | 2022 | 18 | 0.870 |
Why?
|
| Coenzyme A | 1 | 2022 | 39 | 0.860 |
Why?
|
| Neoplasm Proteins | 5 | 2021 | 3703 | 0.840 |
Why?
|
| S-Phase Kinase-Associated Proteins | 3 | 2018 | 90 | 0.810 |
Why?
|
| Cell Proliferation | 10 | 2022 | 10481 | 0.790 |
Why?
|
| Cytoskeletal Proteins | 4 | 2011 | 1364 | 0.780 |
Why?
|
| Cell Line, Tumor | 28 | 2023 | 16689 | 0.780 |
Why?
|
| Enzyme Activation | 34 | 2016 | 3701 | 0.770 |
Why?
|
| Mammary Glands, Human | 3 | 2017 | 199 | 0.760 |
Why?
|
| Biogenic Polyamines | 1 | 2020 | 4 | 0.750 |
Why?
|
| Eflornithine | 1 | 2020 | 31 | 0.740 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2021 | 5172 | 0.730 |
Why?
|
| Second Messenger Systems | 3 | 2012 | 206 | 0.730 |
Why?
|
| Ornithine Decarboxylase | 1 | 2020 | 63 | 0.730 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2024 | 1285 | 0.700 |
Why?
|
| MAP Kinase Signaling System | 3 | 2024 | 1526 | 0.700 |
Why?
|
| Cytotoxins | 1 | 2020 | 153 | 0.690 |
Why?
|
| Access to Information | 1 | 2021 | 320 | 0.650 |
Why?
|
| Pyrimidines | 3 | 2021 | 2942 | 0.640 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2020 | 5535 | 0.640 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 35 | 0.620 |
Why?
|
| Genes, Neoplasm | 1 | 2019 | 376 | 0.610 |
Why?
|
| Cystine | 1 | 2017 | 95 | 0.610 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 675 | 0.610 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2021 | 1861 | 0.610 |
Why?
|
| Actins | 7 | 2010 | 2121 | 0.610 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 10 | 2022 | 437 | 0.610 |
Why?
|
| HeLa Cells | 13 | 2017 | 3128 | 0.600 |
Why?
|
| Phosphatidylinositol Phosphates | 7 | 2015 | 209 | 0.590 |
Why?
|
| Eukaryotic Cells | 2 | 2012 | 198 | 0.570 |
Why?
|
| NF-kappa B | 6 | 2005 | 2499 | 0.570 |
Why?
|
| Protein Kinases | 3 | 2013 | 1640 | 0.570 |
Why?
|
| Oxidative Stress | 8 | 2016 | 3086 | 0.560 |
Why?
|
| Neoplasms | 16 | 2023 | 21683 | 0.540 |
Why?
|
| Food Deprivation | 1 | 2016 | 116 | 0.540 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2014 | 337 | 0.530 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 1097 | 0.530 |
Why?
|
| Methionine | 1 | 2017 | 590 | 0.520 |
Why?
|
| Immunoblotting | 8 | 2017 | 1682 | 0.520 |
Why?
|
| Serine | 9 | 2016 | 826 | 0.510 |
Why?
|
| Glutamic Acid | 2 | 2017 | 1169 | 0.500 |
Why?
|
| TOR Serine-Threonine Kinases | 9 | 2021 | 2109 | 0.500 |
Why?
|
| Diet Therapy | 1 | 2016 | 154 | 0.500 |
Why?
|
| Cysteine | 4 | 2022 | 874 | 0.490 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 276 | 0.490 |
Why?
|
| Publishing | 1 | 2021 | 833 | 0.480 |
Why?
|
| Animals | 71 | 2021 | 168757 | 0.470 |
Why?
|
| STAT3 Transcription Factor | 2 | 2023 | 873 | 0.470 |
Why?
|
| Glutathione | 1 | 2016 | 589 | 0.460 |
Why?
|
| Adherens Junctions | 1 | 2013 | 90 | 0.450 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1660 | 0.430 |
Why?
|
| Neutrophil Infiltration | 1 | 2015 | 390 | 0.420 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2016 | 1142 | 0.420 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2012 | 111 | 0.410 |
Why?
|
| Diglycerides | 5 | 2012 | 176 | 0.410 |
Why?
|
| Interleukin-8 | 1 | 2015 | 690 | 0.410 |
Why?
|
| Glypicans | 1 | 2011 | 34 | 0.410 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2021 | 520 | 0.400 |
Why?
|
| Drug Discovery | 1 | 2019 | 1058 | 0.400 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 3 | 2012 | 127 | 0.400 |
Why?
|
| Multiprotein Complexes | 6 | 2021 | 1119 | 0.390 |
Why?
|
| ADAM Proteins | 2 | 2010 | 243 | 0.390 |
Why?
|
| Antibodies | 2 | 2013 | 2460 | 0.380 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2021 | 8428 | 0.380 |
Why?
|
| Golgi Apparatus | 2 | 2010 | 410 | 0.380 |
Why?
|
| Nuclear Proteins | 6 | 2021 | 5853 | 0.380 |
Why?
|
| Spheroids, Cellular | 4 | 2016 | 351 | 0.370 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2021 | 3557 | 0.370 |
Why?
|
| NIH 3T3 Cells | 5 | 2017 | 677 | 0.370 |
Why?
|
| Humans | 100 | 2024 | 744343 | 0.370 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2014 | 1990 | 0.370 |
Why?
|
| Neoplastic Processes | 1 | 2009 | 35 | 0.360 |
Why?
|
| Substrate Specificity | 8 | 2017 | 1801 | 0.350 |
Why?
|
| Models, Biological | 9 | 2014 | 9583 | 0.350 |
Why?
|
| Vesicular Transport Proteins | 1 | 2012 | 377 | 0.350 |
Why?
|
| Receptors, Steroid | 1 | 2010 | 155 | 0.350 |
Why?
|
| Endothelial Cells | 2 | 2020 | 3479 | 0.340 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2009 | 103 | 0.340 |
Why?
|
| HEK293 Cells | 7 | 2020 | 4204 | 0.340 |
Why?
|
| Piperazines | 1 | 2019 | 2488 | 0.340 |
Why?
|
| Immediate-Early Proteins | 2 | 2010 | 453 | 0.340 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2011 | 4554 | 0.330 |
Why?
|
| DNA Damage | 2 | 2017 | 2432 | 0.330 |
Why?
|
| Immunoprecipitation | 5 | 2015 | 905 | 0.330 |
Why?
|
| RNA Interference | 7 | 2018 | 2889 | 0.330 |
Why?
|
| Transfection | 9 | 2016 | 5892 | 0.330 |
Why?
|
| Cell Line | 12 | 2020 | 15997 | 0.320 |
Why?
|
| Blood Proteins | 5 | 2003 | 1124 | 0.320 |
Why?
|
| Neoplasm Metastasis | 3 | 2008 | 4851 | 0.320 |
Why?
|
| Cytoskeleton | 3 | 2010 | 1185 | 0.320 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 1152 | 0.320 |
Why?
|
| Mice, Nude | 5 | 2021 | 3689 | 0.310 |
Why?
|
| Mutation | 14 | 2017 | 29786 | 0.310 |
Why?
|
| Wnt Proteins | 1 | 2011 | 721 | 0.300 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2024 | 452 | 0.290 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 430 | 0.290 |
Why?
|
| Fibrosarcoma | 1 | 2008 | 348 | 0.280 |
Why?
|
| Receptor, erbB-2 | 2 | 2016 | 2416 | 0.280 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.280 |
Why?
|
| Molecular Sequence Data | 18 | 2012 | 18111 | 0.280 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18029 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 2916 | 0.280 |
Why?
|
| Tetradecanoylphorbol Acetate | 6 | 2008 | 821 | 0.280 |
Why?
|
| Mice | 30 | 2021 | 81183 | 0.280 |
Why?
|
| Cell Migration Inhibition | 1 | 2005 | 96 | 0.270 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2009 | 638 | 0.270 |
Why?
|
| Amino Acid Motifs | 8 | 2015 | 936 | 0.270 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2024 | 697 | 0.270 |
Why?
|
| Neutrophils | 4 | 2015 | 3719 | 0.270 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 7913 | 0.270 |
Why?
|
| Oncogenes | 1 | 2012 | 1265 | 0.270 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2020 | 1338 | 0.270 |
Why?
|
| Disintegrins | 1 | 2005 | 25 | 0.260 |
Why?
|
| Amino Acid Sequence | 16 | 2012 | 13815 | 0.260 |
Why?
|
| Tyrosine | 3 | 2003 | 1461 | 0.260 |
Why?
|
| Protein Multimerization | 1 | 2010 | 970 | 0.260 |
Why?
|
| Aspirin | 1 | 2016 | 3282 | 0.250 |
Why?
|
| Forkhead Transcription Factors | 2 | 2009 | 1613 | 0.240 |
Why?
|
| Proline | 2 | 2016 | 458 | 0.240 |
Why?
|
| Cell Survival | 4 | 2014 | 5882 | 0.240 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 191 | 0.240 |
Why?
|
| Biochemistry | 1 | 2005 | 113 | 0.240 |
Why?
|
| Female | 36 | 2024 | 380194 | 0.240 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 4 | 2009 | 59 | 0.240 |
Why?
|
| Mitogens | 1 | 2024 | 232 | 0.230 |
Why?
|
| Cell Nucleus | 3 | 2009 | 2969 | 0.230 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 2 | 2017 | 177 | 0.230 |
Why?
|
| Sequence Alignment | 6 | 2012 | 2256 | 0.230 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 396 | 0.230 |
Why?
|
| Enzyme Inhibitors | 12 | 2015 | 3798 | 0.230 |
Why?
|
| Stilbenes | 1 | 2004 | 156 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2005 | 2077 | 0.230 |
Why?
|
| Antineoplastic Agents | 5 | 2021 | 13695 | 0.220 |
Why?
|
| Mice, Transgenic | 5 | 2020 | 9734 | 0.220 |
Why?
|
| Protein Structure, Tertiary | 6 | 2014 | 3846 | 0.220 |
Why?
|
| Nerve Growth Factor | 1 | 2023 | 149 | 0.210 |
Why?
|
| Apoptosis | 4 | 2024 | 9727 | 0.210 |
Why?
|
| Antigens, Surface | 3 | 2002 | 1663 | 0.210 |
Why?
|
| Integrins | 3 | 2002 | 846 | 0.210 |
Why?
|
| Acetyl Coenzyme A | 1 | 2022 | 74 | 0.210 |
Why?
|
| Cell Growth Processes | 3 | 2013 | 399 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2017 | 2942 | 0.210 |
Why?
|
| Membrane Proteins | 3 | 2012 | 7880 | 0.200 |
Why?
|
| Neoplastic Stem Cells | 2 | 2021 | 1376 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2024 | 648 | 0.190 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2021 | 185 | 0.190 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2023 | 143 | 0.190 |
Why?
|
| Molecular Conformation | 2 | 2019 | 563 | 0.190 |
Why?
|
| Lipid Metabolism | 6 | 2022 | 1889 | 0.190 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 822 | 0.190 |
Why?
|
| Genes, Reporter | 4 | 2006 | 1547 | 0.190 |
Why?
|
| Systems Biology | 1 | 2023 | 469 | 0.180 |
Why?
|
| Ubiquitination | 4 | 2017 | 1012 | 0.180 |
Why?
|
| Doxorubicin | 2 | 2017 | 2234 | 0.170 |
Why?
|
| Stromal Cells | 3 | 2012 | 1355 | 0.170 |
Why?
|
| Receptors, Thrombin | 2 | 1996 | 131 | 0.170 |
Why?
|
| Neovascularization, Pathologic | 2 | 2012 | 2635 | 0.170 |
Why?
|
| Protein Methyltransferases | 1 | 2019 | 55 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 6 | 2013 | 6314 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1655 | 0.160 |
Why?
|
| Stress, Mechanical | 1 | 2024 | 1686 | 0.160 |
Why?
|
| Proteins | 3 | 2020 | 6103 | 0.160 |
Why?
|
| Phenylurea Compounds | 1 | 2021 | 528 | 0.160 |
Why?
|
| Protein Kinase C-delta | 4 | 2004 | 123 | 0.160 |
Why?
|
| Aspartic Acid | 1 | 2020 | 576 | 0.160 |
Why?
|
| Cell Communication | 1 | 2005 | 1621 | 0.150 |
Why?
|
| Amino Acids | 2 | 2021 | 1736 | 0.150 |
Why?
|
| Nucleotides | 1 | 2020 | 464 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2010 | 1213 | 0.150 |
Why?
|
| p21-Activated Kinases | 4 | 2014 | 128 | 0.150 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2017 | 21 | 0.150 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 2016 | 77 | 0.150 |
Why?
|
| Serum Amyloid P-Component | 1 | 2017 | 47 | 0.150 |
Why?
|
| Threonine | 3 | 2003 | 279 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2014 | 2915 | 0.140 |
Why?
|
| Cells, Cultured | 5 | 2020 | 19229 | 0.140 |
Why?
|
| Cell Physiological Phenomena | 1 | 1998 | 154 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2023 | 658 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 12072 | 0.140 |
Why?
|
| Buthionine Sulfoximine | 1 | 2016 | 18 | 0.140 |
Why?
|
| 3T3 Cells | 5 | 2003 | 1101 | 0.140 |
Why?
|
| Protein Binding | 13 | 2017 | 9386 | 0.140 |
Why?
|
| Carbachol | 2 | 2004 | 226 | 0.140 |
Why?
|
| Integrin alpha6beta4 | 4 | 2005 | 31 | 0.140 |
Why?
|
| Casein Kinase II | 1 | 2017 | 128 | 0.140 |
Why?
|
| Colonic Neoplasms | 3 | 2005 | 2541 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 736 | 0.140 |
Why?
|
| Antioxidants | 1 | 2004 | 1663 | 0.140 |
Why?
|
| Membrane Lipids | 1 | 1997 | 248 | 0.140 |
Why?
|
| Microvessels | 1 | 2020 | 544 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 2025 | 0.130 |
Why?
|
| Liver | 2 | 2017 | 7474 | 0.130 |
Why?
|
| Cell Compartmentation | 3 | 2008 | 402 | 0.130 |
Why?
|
| Isoxazoles | 1 | 2017 | 216 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 2015 | 0.130 |
Why?
|
| Biosynthetic Pathways | 1 | 2016 | 137 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2020 | 1133 | 0.130 |
Why?
|
| Lacrimal Apparatus | 3 | 2004 | 225 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2010 | 3772 | 0.130 |
Why?
|
| Laminin | 3 | 2006 | 419 | 0.130 |
Why?
|
| Lipogenesis | 1 | 2017 | 212 | 0.130 |
Why?
|
| Platelet-Derived Growth Factor | 6 | 2000 | 625 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 2203 | 0.130 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2016 | 290 | 0.130 |
Why?
|
| Inositol Phosphates | 1 | 1994 | 180 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2016 | 4217 | 0.120 |
Why?
|
| Homocysteine | 1 | 2017 | 647 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 4 | 2021 | 2727 | 0.120 |
Why?
|
| Substance P | 1 | 1995 | 335 | 0.120 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 11124 | 0.120 |
Why?
|
| Drug Therapy | 1 | 2017 | 497 | 0.120 |
Why?
|
| Salivary Glands | 1 | 1995 | 229 | 0.120 |
Why?
|
| Metabolomics | 1 | 2022 | 1484 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1996 | 641 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-abl | 2 | 2004 | 146 | 0.110 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 553 | 0.110 |
Why?
|
| I-kappa B Proteins | 2 | 2005 | 225 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 377 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 611 | 0.110 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2012 | 16 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2010 | 3505 | 0.110 |
Why?
|
| Phosphopeptides | 2 | 2013 | 241 | 0.110 |
Why?
|
| Lamin Type A | 1 | 2014 | 190 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2014 | 2967 | 0.110 |
Why?
|
| Blood Platelets | 4 | 2001 | 2508 | 0.110 |
Why?
|
| Transcription Factors | 3 | 2021 | 12208 | 0.110 |
Why?
|
| Gene Expression | 2 | 2017 | 7799 | 0.110 |
Why?
|
| Glutamine | 1 | 2016 | 578 | 0.110 |
Why?
|
| Hyperplasia | 1 | 2016 | 1185 | 0.110 |
Why?
|
| DNA Primers | 2 | 2010 | 2892 | 0.110 |
Why?
|
| Glycine | 1 | 2016 | 671 | 0.110 |
Why?
|
| Protein Phosphatase 2 | 1 | 2014 | 229 | 0.110 |
Why?
|
| Mitochondria | 1 | 2005 | 3520 | 0.110 |
Why?
|
| Retinoblastoma Protein | 1 | 2016 | 704 | 0.110 |
Why?
|
| Proteoglycans | 2 | 2006 | 835 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 1997 | 1081 | 0.100 |
Why?
|
| Androstadienes | 7 | 2001 | 346 | 0.100 |
Why?
|
| Biological Transport | 3 | 2004 | 2118 | 0.100 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1878 | 0.100 |
Why?
|
| Arginine | 1 | 2016 | 944 | 0.100 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2012 | 114 | 0.100 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 390 | 0.100 |
Why?
|
| Protein Stability | 2 | 2010 | 557 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2012 | 147 | 0.100 |
Why?
|
| src-Family Kinases | 2 | 2004 | 551 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases | 3 | 2000 | 205 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2505 | 0.090 |
Why?
|
| Hydrogen Peroxide | 2 | 2005 | 731 | 0.090 |
Why?
|
| Proteomics | 1 | 2024 | 3638 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2085 | 0.090 |
Why?
|
| Cell Membrane | 6 | 2010 | 3748 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 1801 | 0.090 |
Why?
|
| Drug Combinations | 2 | 2006 | 1959 | 0.090 |
Why?
|
| Cisplatin | 1 | 2016 | 1662 | 0.090 |
Why?
|
| Cullin Proteins | 1 | 2010 | 180 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 436 | 0.090 |
Why?
|
| Cell Shape | 1 | 2010 | 375 | 0.080 |
Why?
|
| Calcium | 5 | 2012 | 5756 | 0.080 |
Why?
|
| Enzyme Induction | 1 | 2009 | 475 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2003 | 6622 | 0.080 |
Why?
|
| Precipitin Tests | 4 | 2003 | 829 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 9648 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2024 | 11483 | 0.080 |
Why?
|
| Cross Reactions | 1 | 2010 | 841 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2012 | 1539 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11524 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2009 | 168 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2013 | 1915 | 0.080 |
Why?
|
| Binding Sites | 7 | 2015 | 6114 | 0.080 |
Why?
|
| 14-3-3 Proteins | 1 | 2008 | 214 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 323 | 0.080 |
Why?
|
| Sequence Deletion | 2 | 2010 | 1526 | 0.070 |
Why?
|
| Protein Kinase C-epsilon | 3 | 2002 | 43 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.070 |
Why?
|
| Spodoptera | 2 | 2019 | 153 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 871 | 0.070 |
Why?
|
| Collagen | 2 | 2006 | 2689 | 0.070 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1420 | 0.070 |
Why?
|
| Ionomycin | 1 | 2006 | 109 | 0.070 |
Why?
|
| beta Catenin | 1 | 2011 | 1059 | 0.070 |
Why?
|
| Ionophores | 1 | 2006 | 108 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1678 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 10943 | 0.070 |
Why?
|
| Integrin alpha2beta1 | 1 | 2005 | 17 | 0.070 |
Why?
|
| DNA Repair | 1 | 2015 | 2046 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2012 | 1534 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1783 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2008 | 645 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 3778 | 0.060 |
Why?
|
| Transport Vesicles | 1 | 2005 | 83 | 0.060 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2005 | 70 | 0.060 |
Why?
|
| Base Sequence | 3 | 2003 | 12797 | 0.060 |
Why?
|
| Drug Synergism | 2 | 2021 | 1792 | 0.060 |
Why?
|
| Alleles | 3 | 2005 | 6933 | 0.060 |
Why?
|
| Phosphotyrosine | 2 | 2003 | 457 | 0.060 |
Why?
|
| Phosphoserine | 3 | 2014 | 206 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 4751 | 0.060 |
Why?
|
| Guanosine Diphosphate | 2 | 2001 | 85 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2012 | 2740 | 0.060 |
Why?
|
| Vanadates | 1 | 2003 | 82 | 0.060 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2003 | 12 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 258 | 0.060 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2016 | 474 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2006 | 611 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 625 | 0.060 |
Why?
|
| Cyclosporine | 1 | 2006 | 786 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2005 | 380 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2006 | 600 | 0.060 |
Why?
|
| Peptide Library | 1 | 2004 | 349 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 3462 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 158 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 597 | 0.050 |
Why?
|
| COS Cells | 3 | 2005 | 1161 | 0.050 |
Why?
|
| Okadaic Acid | 1 | 2002 | 67 | 0.050 |
Why?
|
| Plasmids | 2 | 2005 | 2307 | 0.050 |
Why?
|
| Time Factors | 4 | 2016 | 40075 | 0.050 |
Why?
|
| Phospholipases | 1 | 2002 | 72 | 0.050 |
Why?
|
| Cytosol | 1 | 2005 | 901 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2004 | 5179 | 0.050 |
Why?
|
| Gene Fusion | 2 | 2017 | 371 | 0.050 |
Why?
|
| Platelet Aggregation | 2 | 1995 | 798 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2017 | 2849 | 0.050 |
Why?
|
| Oncogene Protein v-akt | 2 | 2014 | 135 | 0.050 |
Why?
|
| S Phase | 2 | 2000 | 423 | 0.050 |
Why?
|
| Nervous System | 1 | 2005 | 554 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2021 | 2716 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2699 | 0.050 |
Why?
|
| Conserved Sequence | 2 | 2005 | 1202 | 0.050 |
Why?
|
| Casein Kinase I | 2 | 2012 | 47 | 0.050 |
Why?
|
| Necrosis | 1 | 2005 | 1643 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2004 | 627 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 433 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2005 | 852 | 0.050 |
Why?
|
| Gelsolin | 2 | 2001 | 190 | 0.050 |
Why?
|
| Calmodulin | 1 | 2001 | 209 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 742 | 0.050 |
Why?
|
| Histone Deacetylases | 1 | 2005 | 728 | 0.050 |
Why?
|
| Desmosomes | 1 | 1999 | 73 | 0.040 |
Why?
|
| Plicamycin | 1 | 2019 | 13 | 0.040 |
Why?
|
| Pseudopodia | 1 | 1999 | 172 | 0.040 |
Why?
|
| Peptide Fragments | 4 | 2001 | 5097 | 0.040 |
Why?
|
| Models, Structural | 1 | 1998 | 361 | 0.040 |
Why?
|
| Helminth Proteins | 1 | 1999 | 171 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2005 | 1538 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2008 | 4161 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2002 | 646 | 0.040 |
Why?
|
| G1 Phase | 1 | 1999 | 415 | 0.040 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2004 | 828 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 5867 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3870 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2002 | 1899 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2001 | 772 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3508 | 0.040 |
Why?
|
| Cytochalasin B | 1 | 1996 | 74 | 0.040 |
Why?
|
| Synaptotagmins | 1 | 1997 | 58 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2017 | 203 | 0.040 |
Why?
|
| Protein Kinase C-alpha | 3 | 2004 | 112 | 0.040 |
Why?
|
| Cell Death | 1 | 2003 | 1706 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 635 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2010 | 5021 | 0.040 |
Why?
|
| Receptors, Erythropoietin | 1 | 1997 | 147 | 0.040 |
Why?
|
| Hydroxylation | 1 | 2016 | 141 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 188 | 0.040 |
Why?
|
| Cyclin D | 1 | 2016 | 71 | 0.030 |
Why?
|
| src Homology Domains | 1 | 1997 | 364 | 0.030 |
Why?
|
| Chemotaxis | 1 | 1999 | 607 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2001 | 721 | 0.030 |
Why?
|
| Erythroid Precursor Cells | 1 | 1997 | 218 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2021 | 859 | 0.030 |
Why?
|
| Methylation | 1 | 2019 | 1106 | 0.030 |
Why?
|
| Male | 8 | 2016 | 350118 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2001 | 4011 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 393 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2023 | 1708 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2010 | 13033 | 0.030 |
Why?
|
| Genistein | 1 | 1995 | 88 | 0.030 |
Why?
|
| Receptor, Insulin | 2 | 1999 | 846 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 408 | 0.030 |
Why?
|
| Dimerization | 1 | 1997 | 893 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2005 | 3494 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 692 | 0.030 |
Why?
|
| Baculoviridae | 1 | 1994 | 118 | 0.030 |
Why?
|
| GTP-Binding Proteins | 2 | 1997 | 970 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 670 | 0.030 |
Why?
|
| Isoflavones | 1 | 1995 | 139 | 0.030 |
Why?
|
| Cyclin A2 | 1 | 2014 | 21 | 0.030 |
Why?
|
| Peptides | 2 | 2005 | 4409 | 0.030 |
Why?
|
| Phosphothreonine | 1 | 2014 | 63 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14557 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 1866 | 0.030 |
Why?
|
| Staurosporine | 1 | 1995 | 251 | 0.030 |
Why?
|
| Flow Cytometry | 4 | 2012 | 5974 | 0.030 |
Why?
|
| Alkaloids | 1 | 1995 | 190 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 761 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2016 | 322 | 0.030 |
Why?
|
| Disease Progression | 1 | 2010 | 13284 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2014 | 191 | 0.030 |
Why?
|
| rac GTP-Binding Proteins | 3 | 2001 | 164 | 0.030 |
Why?
|
| Type C Phospholipases | 2 | 2006 | 292 | 0.030 |
Why?
|
| Rats | 6 | 2004 | 24260 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 4420 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 708 | 0.030 |
Why?
|
| Olfactory Bulb | 1 | 2014 | 200 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2016 | 538 | 0.030 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2012 | 45 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1999 | 852 | 0.030 |
Why?
|
| Tumor Microenvironment | 2 | 2016 | 3586 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 3 | 2004 | 2088 | 0.030 |
Why?
|
| Tubulin | 1 | 1995 | 695 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 2012 | 281 | 0.030 |
Why?
|
| Vietnam | 1 | 2012 | 408 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 3768 | 0.020 |
Why?
|
| Point Mutation | 1 | 1997 | 1623 | 0.020 |
Why?
|
| Oligopeptides | 1 | 1996 | 1189 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2001 | 222 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2017 | 1149 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 2455 | 0.020 |
Why?
|
| Lipids | 2 | 1999 | 3305 | 0.020 |
Why?
|
| Epithelium | 1 | 1995 | 1679 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 1999 | 1419 | 0.020 |
Why?
|
| Transduction, Genetic | 2 | 2004 | 913 | 0.020 |
Why?
|
| Mexico | 1 | 2012 | 690 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 345 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1997 | 1988 | 0.020 |
Why?
|
| Stem Cells | 1 | 2023 | 3567 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2012 | 0.020 |
Why?
|
| Acetylation | 1 | 2012 | 1085 | 0.020 |
Why?
|
| Cell Division | 1 | 1997 | 4568 | 0.020 |
Why?
|
| Guinea Pigs | 2 | 2001 | 1386 | 0.020 |
Why?
|
| Adenoviridae | 2 | 2004 | 1099 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2017 | 2019 | 0.020 |
Why?
|
| DNA | 1 | 2003 | 7301 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 1950 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3647 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 2 | 2001 | 4462 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1692 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 494 | 0.020 |
Why?
|
| Lysine | 1 | 2012 | 1007 | 0.020 |
Why?
|
| Luminescent Proteins | 2 | 2002 | 853 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 907 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 2948 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12951 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1294 | 0.020 |
Why?
|
| Epidermal Growth Factor | 2 | 1999 | 708 | 0.020 |
Why?
|
| Kinetics | 3 | 2001 | 6473 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 349 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 1723 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 5456 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2012 | 1101 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2004 | 74 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2009 | 1252 | 0.020 |
Why?
|
| Rabbits | 2 | 2001 | 4894 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 401 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 2839 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2004 | 301 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2004 | 177 | 0.010 |
Why?
|
| Autophagy | 1 | 2011 | 1300 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4186 | 0.010 |
Why?
|
| Phospholipids | 2 | 1999 | 784 | 0.010 |
Why?
|
| Protein Transport | 1 | 2009 | 1988 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1995 | 3690 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2004 | 8301 | 0.010 |
Why?
|
| Marine Toxins | 1 | 2001 | 24 | 0.010 |
Why?
|
| Viral Envelope Proteins | 1 | 2005 | 635 | 0.010 |
Why?
|
| Actin-Related Protein 2 | 1 | 2001 | 40 | 0.010 |
Why?
|
| Actin-Related Protein 3 | 1 | 2001 | 48 | 0.010 |
Why?
|
| Thionucleotides | 1 | 2001 | 107 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2001 | 88 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2001 | 363 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 462 | 0.010 |
Why?
|
| Immune Sera | 1 | 2001 | 641 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 203 | 0.010 |
Why?
|
| Insulin | 1 | 1995 | 6580 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 6386 | 0.010 |
Why?
|
| Neutrophil Activation | 1 | 2001 | 186 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2001 | 683 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 112 | 0.010 |
Why?
|
| Oxazoles | 1 | 2001 | 189 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2000 | 180 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2001 | 1095 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2001 | 595 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11366 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2001 | 2255 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1970 | 0.010 |
Why?
|
| Hemostasis | 1 | 2001 | 458 | 0.010 |
Why?
|
| Keratins | 1 | 1999 | 515 | 0.010 |
Why?
|
| Carbazoles | 1 | 1999 | 226 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 2001 | 509 | 0.010 |
Why?
|
| Sphingolipids | 1 | 1999 | 159 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 547 | 0.010 |
Why?
|
| Valine | 1 | 1999 | 413 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 2050 | 0.010 |
Why?
|
| Myristates | 1 | 1997 | 13 | 0.010 |
Why?
|
| Cell Size | 1 | 1999 | 643 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1997 | 40 | 0.010 |
Why?
|
| Glucosides | 1 | 2001 | 451 | 0.010 |
Why?
|
| Alanine | 1 | 1999 | 572 | 0.010 |
Why?
|
| Adrenergic Agents | 1 | 1997 | 70 | 0.010 |
Why?
|
| Cholinergic Agents | 1 | 1997 | 93 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1940 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1997 | 179 | 0.010 |
Why?
|
| Naphthalenes | 1 | 1997 | 194 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1995 | 104 | 0.010 |
Why?
|
| ras Proteins | 1 | 2001 | 1060 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1995 | 330 | 0.010 |
Why?
|
| Chromones | 1 | 1995 | 154 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 1266 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 7722 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1995 | 321 | 0.010 |
Why?
|
| Centrosome | 1 | 1995 | 201 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 491 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1995 | 293 | 0.010 |
Why?
|
| Polymers | 1 | 2001 | 1621 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1995 | 590 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1997 | 1901 | 0.010 |
Why?
|
| CHO Cells | 1 | 1995 | 1406 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1997 | 726 | 0.010 |
Why?
|
| DNA Replication | 1 | 1999 | 1399 | 0.010 |
Why?
|
| Morpholines | 1 | 1995 | 571 | 0.010 |
Why?
|
| Cricetinae | 1 | 1995 | 2472 | 0.010 |
Why?
|
| Algorithms | 1 | 2012 | 13881 | 0.010 |
Why?
|
| Platelet Activation | 1 | 1995 | 673 | 0.010 |
Why?
|
| Phosphates | 1 | 1995 | 786 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2001 | 1938 | 0.010 |
Why?
|
| Epitopes | 1 | 1997 | 2571 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1997 | 3129 | 0.010 |
Why?
|
| Indoles | 1 | 1999 | 1839 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1995 | 1086 | 0.010 |
Why?
|
| Antigens | 1 | 1995 | 1466 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1997 | 3002 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1999 | 4034 | 0.000 |
Why?
|
| Phenotype | 1 | 1999 | 16365 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1995 | 9274 | 0.000 |
Why?
|